Year Ended December 31, | |||||||||||
2013 | 2012 | 2011 | |||||||||
(In millions) | |||||||||||
Interest paid, net of amount capitalized | $ | 836 | $ | 579 | $ | 642 | |||||
Income taxes (refunded)/paid (a) | (60 | ) | 17 | 26 | |||||||
Non-cash investing and financing activities: | |||||||||||
Additions to fixed assets for accrued capital expenditures | 405 | 563 | 292 | ||||||||
Decrease to fixed assets for accrued grants and related tax impact | (681 | ) | (87 | ) | (32 | ) | |||||
Decrease to notes receivable for equity conversion | — | — | 63 | ||||||||
Issuance of shares for GenOn acquisition | — | (2,188 | ) | — |